A review of troponins in ischemic heart disease and other conditions

International Journal of Angiology

Volumn 16, Issue 2, 2007, Pages 53-58

  Skeik, Nedaa ^a,b,c   Patel, Deevia Chandrakant ^b,d  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c St Mary's Regional Med Center   (United States)

^d Franklin Medical Center   (United States)

Author keywords

Coronary artery disease; Management; Nonischemic origin of troponin; Prognosis; Troponin

Indexed keywords

EID: 80053034134     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1278248     Document Type: Review

References (67)

1. Antman EM. Decision making with cardiac troponin tests. N Engl J Med 2002;346:2079-82. (Pubitemid 34680601)
2. Adams JE 3rd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993;88:750-63.
3. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
4. Adams JE III, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993;88:101-6. (Pubitemid 23195438)
5. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995;41:1710-5.
6. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998;44:1919-24. (Pubitemid 28405756)
7. Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem 1999;45:2129-35.
8. Schreier T, Kedes L, Gahlmann R. Cloning, structural analysis, and expression of the human slow twitch skeletal muscle/cardiac troponin C gene. J Biol Chem 1990;265:21247-53. (Pubitemid 120014146)
9. Panteghini M, Pagani F, Yeo KT, et al; Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32. (Pubitemid 38156373)
10. Jaffe A, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
11. Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-7. (Pubitemid 29162478)
12. Eggers KM, Oldgren J, Nordenskjold A, Lindhal B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: Limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81. (Pubitemid 39349374)
13. Olatidoye AG, Wu AH, Feng YJ, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998;81:1405-10. (Pubitemid 28283819)
14. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD for the PRISM Study Investigators. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757-62.
15. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5. (Pubitemid 35424746)
16. Dierkes J, Domröse U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-9.
17. Horwich TB, Patel J, McLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-8. (Pubitemid 37022125)
18. Ni CY. Cardiac troponin I: A biomarker for detection and risk stratification of minor myocardial damage. Clin Lab 2001;47:483-92. (Pubitemid 32927030)
19. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L; FRISC II (Fast Revascularization during InStability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: A FRISC II substudy. J Am Coll Cardiol 2001;38:979-86. (Pubitemid 32912698)
20. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis. J Am Coll Cardiol 2001;38:478-85. (Pubitemid 32721777)
21. Ottani F, Galvani M, Nicolini FA, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140:917-27.
22. Becker RC, Cannon C P, Tracy R P, et al. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction. Thrombolysis in Myocardial Ischemia III B Investigators. Am Heart J 1996;131:421-33. (Pubitemid 26086593)
23. Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 1998;98:1831-3.
24. Hamm CW, Heeschen C, Goldmann B et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999;340:1623-9. (Erratum in 1999;341:548).
25. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Pubitemid 32758501)
26. Ohman EM, Armstrong PW, White HD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. Am J Cardiol 1999;84:1281-6.
27. Giannitsis E, Muller-Bardorff M, Lehrke S, et al. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation 2001;104:630-5. (Pubitemid 32738514)
28. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 2002;87:520-4. (Pubitemid 34547973)
29. Panteghini M, Cuccia C, Bonetti G, Giubbini R, Pagani F, Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem 2002;48:1432-6. (Pubitemid 34925778)
30. Apple FS, Murakami MM. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem 2005;51:460-3. (Pubitemid 40175822)
31. Falahati A, Sharkey SW, Christensen D, et al. Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction. Am Heart J 1999;137:332-7. (Pubitemid 29070146)
32. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38:2203-14.
33. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
34. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
35. Fuchs S, Stabile E, Mintz GS, et al. Intravascular ultrasound findings in patients with acute coronary syndromes with and without elevated troponin I level. Am J Cardiol 2002;89:1111-3. (Pubitemid 34462858)
36. Herrmann J, Haude M, Lerman A, et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001;103:2339-45. (Pubitemid 32448797)
37. Carrier M, Pellerin M, Perrault L P, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000;69:435-40. (Pubitemid 30127872)
38. Landesberg G, Shatz V, Akopnik I, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003;42:1547-54. (Pubitemid 37378430)
39. Greenson N, Macoviak J, Krishnaswamy P, et al. Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J 2001;141:447-55. (Pubitemid 32200275)
40. Lehrke S, Steen H, Sievers HH, et al. Cardiac troponin T for prediction of short and long-term morbidity and mortality after elective open heart surgery. Clin Chem 2004;50:1560-7. (Pubitemid 39121224)
41. Jeremias A, Gibson M. Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med.2005;142:786-91. (Pubitemid 40593781)
42. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol 2001;87:994-9. (Pubitemid 32299986)
43. Khan IA, Tun A, Wattanasauwan N, et al. Elevation of serum cardiac troponin I in noncardiac and cardiac diseases other than acute coronary syndromes. Am J Emerg Med 1999;17:225-9. (Pubitemid 29218254)
44. Zeng L, Chen Y, Wu M. Cardiac troponin I: A marker for detecting non-ischemic cardiac injury. Zhonghua Yi Xue Za Zhi 2001;81:393-5.
45. Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ 2005;173:1191-202. (Pubitemid 41637819)
46. Errata in 2005;173:1490; 2006;174:353
47. Ammann P, Maggiorini M, Bertel O, et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003;41:2004-9. (Pubitemid 36677123)
48. Morrow D. Cardiac-specific troponins beyond ischemic heart disease. In: Wu AH, ed. Cardiac Markers. 2nd edn. Totowa, New Jersey: Humana Press Inc; 2003: 149-70.
49. Francis GS, Tang WH. Cardiac troponins in renal insufficiency and other non-ischemic cardiac conditions. Prog Cardiovasc Dis 2004;47:196-206. (Pubitemid 40037319)
50. Gerhardt W, Nordin G, Herbert AK, et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000;46:817-21. (Pubitemid 30397445)
51. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005;352:98-100.
52. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency. J Am Coll Cardiol 2002;40:2065-71.
53. Iliou MC, Fumeron C, Benoit MO, et al. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001;16:1452-8. (Pubitemid 32640603)
54. Lowbeer C, Ottosson-Seeberger A, Gustafsson SA, Norrman R, Hulting J, Gutierrez A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant 1999;14:1948-55. (Pubitemid 29358893)
55. Porter GA, Norton TL, Lindsley J, Stevens JS, Phillips DS, Bennett WM. Relationship between elevated serum troponin values in end-stage renal disease patients and abnormal isotopic cardiac scans following stress. Ren Fail 2003;25:55-65. (Pubitemid 36237419)
56. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000;83:205-9. (Pubitemid 30305552)
57. Scott B, Deman A, Peeters P, et al. Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients. Nephrol Dial Transplant 2003;18:737-42. (Pubitemid 36432256)
58. Hung SY, Hung YM, Fang HC, et al. Cardiac troponin I and creatine kinase isoenzyme MB in patients with intradialytic hypotension. Blood Purif 2004;22:338-43.
59. deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353-9. (Pubitemid 37430521)
60. Jung HH, Ma KR, Han H. Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients. Nephrol Dial Transplant 2004;19:3117-23. (Pubitemid 40057637)
61. Goicoechea M, Garca de Vinuesa S, Gómez-Campderá F, et al. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk. Am J Kidney Dis 2004;43:846-53. (Pubitemid 38529622)
62. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002;346:2047-52. (Pubitemid 34680596)
63. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey S W. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997;43:976-82. (Pubitemid 27246988)
64. Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40:1790. (Lett)
65. Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995;41:312-7.
66. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 1998;13:1709-12. (Pubitemid 28306799)
67. Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 1999;33:471-8. (Pubitemid 29234210)